Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Prices:
Single User PDF: US$ 4,200.00
Departmental Site License (one location, up to 10 users): US$ 5,995.00
Global Site License: US$ 8,400.00
The high growth rates and successful launch of several products recently has kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.
Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected based on analysis of major company pipelines.
Trends are discussed in this report including the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public’s fears and result in higher rates of non-immunization, and these are discussed in this edition of the report.
The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable. Included in this report are current market size and forecast for the following vaccines:
Pediatric Vaccines:
Adult Vaccines:
Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:
Single User PDF: US$ 4,200.00
Departmental Site License (one location, up to 10 users): US$ 5,995.00
Global Site License: US$ 8,400.00
The high growth rates and successful launch of several products recently has kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.
Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected based on analysis of major company pipelines.
Trends are discussed in this report including the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public’s fears and result in higher rates of non-immunization, and these are discussed in this edition of the report.
The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable. Included in this report are current market size and forecast for the following vaccines:
Pediatric Vaccines:
- Combinations
- Hepatitis
- HIB
- MMR
- Pneumococcal
- Poliovirus
- Varicella
- Other Pediatric
Adult Vaccines:
- Cervical Cancer
- Hepatitis
- Influenza
- Pneumococcal
- Travel; DT; Misc.
Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:
- U.S.
- Rest of North America
- South America
- Europe
- Japan
- India
- China
- Rest of World
CHAPTER ONE: EXECUTIVE SUMMARY
THE GLOBAL VACCINES INDUSTRY
Scope and Methodology
Overview
Pediatric Preventative Vaccines
The Market
The Market
Total Market
Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccination
Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
The Effect of U.S. Healthcare Reform
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Diphtheria
Pertussis
Tetanus
Hepatitis B
Poliomyelitis
Enterotoxigenic Escherichia coli
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Measles
Mumps
Rubella
Meningococcal Disease
Parainfluenza Virus Type 3
Pneumococcal Conjugate
Rotavirus
Respiratory Syncytial Virus
Varicella
Pediatric Vaccines in Development
Cost of Vaccines in the United States
The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market
Market Analysis
Leading Products and Competitors
Haemophilus Influenzae Type B Vaccine Market
Market Analysis
Leading Products and Competitors
Measles, Mumps and Rubella Vaccines
Market Analysis
Combination Vaccines Market
Market Analysis
Leading Products and Competitors
Pneumococcal Vaccine
Leading Products and Competitors
Poliovirus Vaccine
Market Analysis
Leading Products and Competitors
Varicella Vaccines
Market Analysis
Leading Products and Competitors
Other Vaccines Market
Market Analysis
Leading Products and Competitors
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Global Influenza Surveillance Program
U.S. Surveillance
Recommendations for Adult Immunizations
WHO International Health Regulations
Adult Vaccine Products
Allergies
Cervical Cancer
Cholera
Dengue Fever
Diphtheria-Tetanus
Hepatitis
Hepatitis A
Hepatitis B
Influenza
Japanese Encephalitis
Malaria
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Yellow Fever
Adult Vaccines in Development
Total Market Size and Forecast
Cervical Cancer Market
Market Analysis
Leading Products and Competitors
Hepatitis Market
Market Analysis
Leading Products and Competitors
Influenza Vaccine Market
Market Analysis
Leading Products and Competitors
Market Analysis
Leading Products and Competitors
Travel, DT, and Miscellaneous Vaccine Market
Market Analysis
Leading Products and Competitors
CHAPTER FIVE: VACCINES MARKET SUMMARY
Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
Pediatric Vaccines
Major Manufacturers’ Market Share
Adult Vaccines
Major Manufacturers’ Market Share
CHAPTER SIX: ISSUES AND TRENDS
Vaccine Safety
Refusal to Immunize
Obesity
Post-Licensure Surveillance
Vaccine Adverse Event Reporting System
The Vaccine Safety Datalink Project
Phase IV studies
The Vaccine Injury Compensation Program
Countermeasures Injury Compensation Program
World Health Organization
Other Initiatives
The Future of Vaccine Safety
Vaccine Shortages
Preventing Shortages in the Developed Countries
Financial incentives
Equitable pricing
Vaccine stockpiles
Preventing Shortages in Developing Nations
Vaccine bonds
Preventing Pandemics
U.S. National Vaccine Plan
Vaccines and Bioterrorism
Overview
Project Bioshield Act
National Bio and Agro-Defense Facility
Vaccine Treatment and Evaluation Units
Anthrax
Smallpox
Tularemia
Viral Hemorrhagic Fevers
DTC Advertising of Vaccines
DNA Vaccination
Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips
Innovations in Vaccine Production
Tobacco Plants
Insects
Nanoparticle Systems
Cloning
CHAPTER SEVEN: COMPANY PROFILES
AlphaVax, Inc.
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Baxter Healthcare
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bharat Biotech
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Celldex Therapeutics
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Crucell /Johnson & Johnson
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Emergent biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial
GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Medimmune
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Merck & Co. Inc
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Nabi Biopharmaceuticals
History and Lines of Business
Strategic Alliance
Vaccine Products
Financial Information
Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic alliances
Vaccine Products
Financial Information
Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
COMPANY DIRECTORY
THE GLOBAL VACCINES INDUSTRY
Scope and Methodology
Overview
Pediatric Preventative Vaccines
The Market
The Market
Total Market
Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccination
Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
The Effect of U.S. Healthcare Reform
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Diphtheria
Pertussis
Tetanus
Hepatitis B
Poliomyelitis
Enterotoxigenic Escherichia coli
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Measles
Mumps
Rubella
Meningococcal Disease
Parainfluenza Virus Type 3
Pneumococcal Conjugate
Rotavirus
Respiratory Syncytial Virus
Varicella
Pediatric Vaccines in Development
Cost of Vaccines in the United States
The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market
Market Analysis
Leading Products and Competitors
Haemophilus Influenzae Type B Vaccine Market
Market Analysis
Leading Products and Competitors
Measles, Mumps and Rubella Vaccines
Market Analysis
Combination Vaccines Market
Market Analysis
Leading Products and Competitors
Pneumococcal Vaccine
Leading Products and Competitors
Poliovirus Vaccine
Market Analysis
Leading Products and Competitors
Varicella Vaccines
Market Analysis
Leading Products and Competitors
Other Vaccines Market
Market Analysis
Leading Products and Competitors
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Global Influenza Surveillance Program
U.S. Surveillance
Recommendations for Adult Immunizations
WHO International Health Regulations
Adult Vaccine Products
Allergies
Cervical Cancer
Cholera
Dengue Fever
Diphtheria-Tetanus
Hepatitis
Hepatitis A
Hepatitis B
Influenza
Japanese Encephalitis
Malaria
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Yellow Fever
Adult Vaccines in Development
Total Market Size and Forecast
Cervical Cancer Market
Market Analysis
Leading Products and Competitors
Hepatitis Market
Market Analysis
Leading Products and Competitors
Influenza Vaccine Market
Market Analysis
Leading Products and Competitors
Market Analysis
Leading Products and Competitors
Travel, DT, and Miscellaneous Vaccine Market
Market Analysis
Leading Products and Competitors
CHAPTER FIVE: VACCINES MARKET SUMMARY
Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
Pediatric Vaccines
Major Manufacturers’ Market Share
Adult Vaccines
Major Manufacturers’ Market Share
CHAPTER SIX: ISSUES AND TRENDS
Vaccine Safety
Refusal to Immunize
Obesity
Post-Licensure Surveillance
Vaccine Adverse Event Reporting System
The Vaccine Safety Datalink Project
Phase IV studies
The Vaccine Injury Compensation Program
Countermeasures Injury Compensation Program
World Health Organization
Other Initiatives
The Future of Vaccine Safety
Vaccine Shortages
Preventing Shortages in the Developed Countries
Financial incentives
Equitable pricing
Vaccine stockpiles
Preventing Shortages in Developing Nations
Vaccine bonds
Preventing Pandemics
U.S. National Vaccine Plan
Vaccines and Bioterrorism
Overview
Project Bioshield Act
National Bio and Agro-Defense Facility
Vaccine Treatment and Evaluation Units
Anthrax
Smallpox
Tularemia
Viral Hemorrhagic Fevers
DTC Advertising of Vaccines
DNA Vaccination
Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips
Innovations in Vaccine Production
Tobacco Plants
Insects
Nanoparticle Systems
Cloning
CHAPTER SEVEN: COMPANY PROFILES
AlphaVax, Inc.
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Baxter Healthcare
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bharat Biotech
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Celldex Therapeutics
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Crucell /Johnson & Johnson
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Emergent biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial
GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Medimmune
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Merck & Co. Inc
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Nabi Biopharmaceuticals
History and Lines of Business
Strategic Alliance
Vaccine Products
Financial Information
Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic alliances
Vaccine Products
Financial Information
Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues
Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues
CHAPTER TWO: INTRODUCTION TO VACCINES
Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2010
Figure 2-1: Attenuated Virus Production
Table 2-2: Vaccine-Preventable Diseases, June 2011
Table 2-3: VAERS Table of Reportable Events Following Vaccination
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Table 3-1: Global Immunization Rates by Vaccine Type (DPT3, BCG, HepB, Yellow Fever, Tetanus, Hib, MCV, Polio) 2009
Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2009
Table 3-3: U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2011
Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2011
Table 3-5: Selected Pediatric Vaccines in Development, June 2011
Table 3-6: World Market for Pediatric Vaccines, 2006-2015
Figure 3-1: Market Share of Pediatric Vaccines by Type 2010
Figure 3-2: Market Share of Pediatric Vaccines, by Type 2015
Table 3-7: World Market for Pediatric Vaccines by Region (U.S., Rest of North America, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions)
Table 3-8: World Pediatric Hepatitis Vaccine Market 2006-2015
Table 3-9: World Hib Vaccine Market, 2006-2015
Table 3-10: World MMR Vaccines Market 2006-2015
Table 3-11: World Combination Vaccines Market 2006-2015
Table 3-12: World Pediatric Pneumococcal Vaccine Market 2006-2015
Table 3-13: World Poliovirus Vaccine Market 2006-2015
Table 3-14: World Varicella Vaccine Market 2006-2015
Table 3-15: World Pediatric Other Vaccines Market 2006-2015
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Table 4-1: Universal Adult Immunization Schedule 2011
Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2011
Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2011
Table 4-4: WHO Pandemic Classification Schedule
Table 4-5: Selected Adult Preventive Vaccines in Development, 2011
Table 4-6: World Market for Adult Preventive Vaccines, 2006-2015
Figure 4-1: Market Share of Adult Vaccines, by Type, 2010
Figure 4-2: Market Share of Adult Vaccines, by Type, 2015
Table 4-7: World Market for Adult Vaccines by Region (U.S., Rest pf North Amer., South America, EU, Japan, India, China, Rest of World) 2006-2015
Table 4-8: World Cervical CancerVaccine Market 2006-2015
Table 4-9: World Hepatitis Vaccine Market 2006-2015
Table 4-10: World Influenza Vaccine Market 2006-2015
Table 4-11: 2010 Estimated Population by Region (Africa, Asia, Europe, N. America, Oceania, South America) and Selected Age Group (in millions)
Table 4-12: World Pneumococcal Vaccine Market 2006-2015
Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2006-2015
CHAPTER FIVE: VACCINES MARKET SUMMARY
Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2006-2015
Figure 5-2: World Market for Vaccines by Type 2006-2015
Table 5-1: The World Vaccines Market by Vaccine Type 2006-2015
Figure 5-3: World Market for Vaccines Share by Type (Pediatric, Adult), 2006, 2010 and 2015
Table 5-2: The World Vaccines Market by Region (U.S, Rest of North Amer., South America, EU, Japan, India, China, ROW) 2006-2015 Revenues (in millions)
Table 5-3: Major Manufacturers’ Shares of the World Vaccine Market, 2010
Figure 5-3: 2010 World Vaccines Market Share, by Leading Competitors
Table 5-4: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2010
Figure 5-4: Market Share of Pediatric Vaccines Market, 2010
Table 5-5: Major Manufacturer’s Shares of the World Adult Vaccine Market 2010
Figure 5-5: Market Share of Adult Vaccines Market 2010
CHAPTER SIX: ISSUES AND TRENDS
Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues
Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues
CHAPTER TWO: INTRODUCTION TO VACCINES
Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2010
Figure 2-1: Attenuated Virus Production
Table 2-2: Vaccine-Preventable Diseases, June 2011
Table 2-3: VAERS Table of Reportable Events Following Vaccination
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Table 3-1: Global Immunization Rates by Vaccine Type (DPT3, BCG, HepB, Yellow Fever, Tetanus, Hib, MCV, Polio) 2009
Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2009
Table 3-3: U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2011
Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2011
Table 3-5: Selected Pediatric Vaccines in Development, June 2011
Table 3-6: World Market for Pediatric Vaccines, 2006-2015
Figure 3-1: Market Share of Pediatric Vaccines by Type 2010
Figure 3-2: Market Share of Pediatric Vaccines, by Type 2015
Table 3-7: World Market for Pediatric Vaccines by Region (U.S., Rest of North America, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions)
Table 3-8: World Pediatric Hepatitis Vaccine Market 2006-2015
Table 3-9: World Hib Vaccine Market, 2006-2015
Table 3-10: World MMR Vaccines Market 2006-2015
Table 3-11: World Combination Vaccines Market 2006-2015
Table 3-12: World Pediatric Pneumococcal Vaccine Market 2006-2015
Table 3-13: World Poliovirus Vaccine Market 2006-2015
Table 3-14: World Varicella Vaccine Market 2006-2015
Table 3-15: World Pediatric Other Vaccines Market 2006-2015
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Table 4-1: Universal Adult Immunization Schedule 2011
Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2011
Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2011
Table 4-4: WHO Pandemic Classification Schedule
Table 4-5: Selected Adult Preventive Vaccines in Development, 2011
Table 4-6: World Market for Adult Preventive Vaccines, 2006-2015
Figure 4-1: Market Share of Adult Vaccines, by Type, 2010
Figure 4-2: Market Share of Adult Vaccines, by Type, 2015
Table 4-7: World Market for Adult Vaccines by Region (U.S., Rest pf North Amer., South America, EU, Japan, India, China, Rest of World) 2006-2015
Table 4-8: World Cervical CancerVaccine Market 2006-2015
Table 4-9: World Hepatitis Vaccine Market 2006-2015
Table 4-10: World Influenza Vaccine Market 2006-2015
Table 4-11: 2010 Estimated Population by Region (Africa, Asia, Europe, N. America, Oceania, South America) and Selected Age Group (in millions)
Table 4-12: World Pneumococcal Vaccine Market 2006-2015
Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2006-2015
CHAPTER FIVE: VACCINES MARKET SUMMARY
Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2006-2015
Figure 5-2: World Market for Vaccines by Type 2006-2015
Table 5-1: The World Vaccines Market by Vaccine Type 2006-2015
Figure 5-3: World Market for Vaccines Share by Type (Pediatric, Adult), 2006, 2010 and 2015
Table 5-2: The World Vaccines Market by Region (U.S, Rest of North Amer., South America, EU, Japan, India, China, ROW) 2006-2015 Revenues (in millions)
Table 5-3: Major Manufacturers’ Shares of the World Vaccine Market, 2010
Figure 5-3: 2010 World Vaccines Market Share, by Leading Competitors
Table 5-4: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2010
Figure 5-4: Market Share of Pediatric Vaccines Market, 2010
Table 5-5: Major Manufacturer’s Shares of the World Adult Vaccine Market 2010
Figure 5-5: Market Share of Adult Vaccines Market 2010
CHAPTER SIX: ISSUES AND TRENDS
Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines
